R01
R01 funding pages collect matching grants, scholarships, benefits, fellowships, and other programs from the FindMyMoney.App directory. Use this page to compare current opportunities, then verify deadlines and eligibility on the official source before applying.
NIH R01 Clinical Trial Required Parent NOFO (PA-25-305): 2026/2027 Guide
Parent NIH Research Project Grant (R01) mechanism requiring a clinical trial, with recurring NIH submission cycles through mid-2028 and 2027 planning-relevant deadlines.
NIH RFA-DA-25-024: High Priority HIV and Substance Use Research (R01 Clinical Trial Optional)
NIH NIDA RFA-DA-25-024 supports high-priority research at the intersection of HIV and substance use, including prevention, treatment, cure, and implementation work with R01 funding flexibility and clinical trials optional.
PA-25-172: Modular R01s in Cancer Control and Population Sciences (R01 Clinical Trial Optional), 2026-2027
An NCI parent R01 notice for population-level cancer research, cancer control science, and implementation-focused projects with recurring submission cycles through the 2027 cycle.
PA-25-303: NIH Research Project Grant (Parent R01 Basic Experimental Studies with Humans Required) 2026-2027
Parent R01 NIH NOFO for basic experimental studies involving humans where the project is clinical-trial-based but still framed as basic research, with recurring NIH standard submission cycles and open competitive peer review.
PAR-24-330: Interventions to Reduce Sleep Health Disparities (R01, Clinical Trials Optional)
A NIH Parent R01 announcement supporting non-pharmacological sleep-health interventions, implementation science, and behavioral strategies to reduce sleep-related health disparities among populations with higher burden of poor sleep outcomes.
PAR-25-322: Stephen I. Katz Early Stage Investigator Research Project Grant (R01 Clinical Trial Not Allowed)
NIH’s ESI-focused R01 parent NOFO for projects in a new research direction without preliminary data, with recurring 2026/2027 due dates and up to a 5-year project period.
PAR-25-337: Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment (R01, Clinical Trial Optional)
NIH funding opportunity for translational R01 projects that pair academic and industrial partners to move diagnostics, imaging, and care-delivery technologies toward real end-user use in pre-clinical, clinical, and non-clinical settings, with up to $499,000 direct costs per year for up to 5 years.
PAR-26-001: Screening, Brief Intervention and Referral to Treatment or Prevention (SBIRT/P) for Alcohol, Tobacco, and Other Drugs (ATOD) Use and Misuse in Adult Populations that Experience Health Disparities
A recurring NIH parent announcement for NIH-defined clinical trial R01 projects that test and scale SBIRT/P interventions for ATOD use and misuse among adults affected by health disparities.
PAR-26-042: Research Grants in Clinical Informatics (R01 Clinical Trial Optional)
NIH’s National Library of Medicine (NLM) is funding R01 research grants to develop scalable clinical informatics methods and tools with a direct-cost cap of $250,000 per year.
PAR-27-072: Bioengineering Research Grants (R01) for Translational Biomedical Engineering
NIH Bioengineering Research Grants support R01 applications that integrate engineering, quantitative, and physical science approaches to create or adapt technologies and methods that can be translated into biomedical solutions, with recurring deadlines across 2026 and 2027 and open intake.